The country's first anti-Ai Chinese medicine "Chan Kunning" to recruit 144 drug testers

reporter 11 from Chengdu Enwei Group was informed that at the beginning of the new year, the country's first to obtain the National Drug Administration drug clinical research approval of the anti-AIDS Chinese medicine "Qian Kunning" for the national collection of 144 AIDS-infected clinical trial drugsAt present, the registration is active, more than 30 people infected with AIDS have signed up to apply for clinical trial drugs" The development of Qian Kunning has gone through nearly 20 yearsIn 1988, The Chairman of Enway Group Xue Yongxin developed a chinese medicine for the treatment of hepatitis B, named "Qian Kunning"In 1990, experts from the Chinese Academy of Preventive Medicine (the predecessor of the Cdc) found in a study that "Chan Kunning" had an inhibitory effect on HIV in vitroIn 1991, "Qian Kunning" was first used for two People infected with AIDS in the process of aiding a broader Sichuan infected peopleIn 1992, Enway Group applied to the State Drug Administration to enter clinical researchSince then, Enway Group has cooperated with more than 20 units at home and abroad to carry out further research on "Qian Kunning", and commissioned ahospital in Chicago to, for the "Chan Kunning" anti-AIDS research and development of a full set of clinicalstandardsSince 1997, Enway Group and the Sichuan Provincial Center for Disease Control and Prevention have cooperated to observe the clinical efficacy of PEOPLE infected with AIDS who take "ChanKunning"According to experts from the provincial CDC who participated in the study that year, 72 people were initially infected, and 35 were infected with long-term medicationAfter clinical observation, "Chan Kunning" to improve the immunity of infected people have some help, the first few cases of infected people testing found that their body load of the virus is decreasingIn 2003, Enway Group was approved by the State Drug Administration: agreed to "Chan Kunning" clinical research, thedruganti-HIV effect and safety of scientific evaluation It is also the first anti-HIV traditional drug approved for clinical research in China Since then, Sichuan Enwei Chinese Medicine Research and Development Co., Ltd and the National Drug Clinical Trials Medical Center AIDS professional base -
-
Beijing Ditan Hospital cooperation, began to conduct clinical research in Henan subjects The clinical study of "Qian Kunning" against HIV was subsequently listed as a major scientific and technological project of the "Fifteenth" of the Ministry of Science and Technology From 2004 to 2005, the company's researchers conducted a six-month clinical study of 144 infected persons in three batches at the of diting Hospital The researchers tested the blood samples they brought back and found that there were chemical stakes After analysis, the reason is that many infected people did not take the prescribed "ChanKunning", while taking chemical anti-HIV drugs At present, Enway Group's clinical research in Henan has been completed According to Sichuan Enwei General Manager of Chinese Medicine Research and Development Co., Ltd Shi Dan revealed that the current research data have not come out, but according to preliminary evaluation shows that the patients who take "Chan Kunning" for one year, some patients have a downward trend in the viral load The resultwass on the surprise But Chairman Xue Yongxin is not satisfied with this, out of the rigorous and realistic scientific spirit, he hopes that the "Qian Kunning" research to achieve convincing results at home and abroad So a bold decision was made: to do another large-scale clinical trial in Sichuan Xue Yongxin said that so far, including in the United States, 5,600 infected people have received "ChanKunning" treatment, all infected people have informed consent, not a single infected person because of "Chan Kunning" died For the national recruitment of AIDS-infected people clinical trial drugs, Xue Yongxin said, will choose an environment elegant , scenic , air fresh place, so that infected people live at ease, to provide six months of free accommodation, drug treatment and related tests, and by the person to provide life care It is understood that the cost of this clinical trial is huge, each patient only check one will spend more than 10,000 yuan, to complete the entire trial estimated to require 6 million yuan According to the general manager of The Dan, the applicant must be confirmed infected with AIDS, the region is not limited Registration and enquiry phone: 028
-
81663333 ext 8482, 8367 (rereproduced from "China News Network")